Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -940.74% vs 38.64% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 26.09% vs 2.13% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 200.00% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Windtree Therapeutics, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -165.09% vs -165.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -940.74% vs 38.64% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 15.00% vs 2.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 26.09% vs 2.13% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 200.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 200.00% vs 0.00% in Sep 2024






